Myriam Armant
- Immunology top 2%
- T-cell and B-cell Immunology 9
- Immune Response and Inflammation 7
- Immunotherapy and Immune Responses 6
- Genetics top 5%
- Virus-based gene therapy research 7
- Mesenchymal stem cell research 6
- Hemoglobinopathies and Related Disorders 6
- Immunology and Allergy top 5%
- Hematology top 5%
- Oncology top 10%
-
- CRISPR and Genetic Engineering 7
- Pluripotent Stem Cells Research 6
- Co-authors
- Marika SarfatiMatthew J. FentonG DelespesseManuel RubioM SarfatiGuy DelespesseG BironVéronique Mateo
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Myriam Armant
52 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 109
- Immunology 1.1k
- Genetics 349
- Immunology and Allergy 138
- Hematology 189
- Oncology 376
Countries citing papers authored by Myriam Armant
This map shows the geographic impact of Myriam Armant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myriam Armant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myriam Armant more than expected).
Fields of papers citing papers by Myriam Armant
This network shows the impact of papers produced by Myriam Armant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myriam Armant. The network helps show where Myriam Armant may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Myriam Armant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 20 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 27 | |
| 6 | 2022 | 57 | |
| 7 | 2022 | 20 | |
| 8 | 2019 | 37 | |
| 9 | 2018 | 59 | |
| 10 | 2018 | 27 | |
| 11 | 2014 | 5 | |
| 12 | 2013 | 20 | |
| 13 | 2011 | 201 | |
| 14 | 2010 | 28 | |
| 15 | 2002 | 154 | |
| 16 | 1999 | 208 | |
| 17 | IL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12-mediated IFN-gamma secretion by CD4+ T cells in the absence of TCR ligation. | 1998 | 57 |
| 18 | 1998 | 122 | |
| 19 | 1996 | 45 | |
| 20 | 1995 | 67 |
About Myriam Armant
Myriam Armant is a scholar working on Genetics, Immunology and Hematology, having authored 55 papers that have together received 2.2k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (9 papers), Virus-based gene therapy research (7 papers), CRISPR and Genetic Engineering (7 papers), Immune Response and Inflammation (7 papers), Immunotherapy and Immune Responses (6 papers), Pluripotent Stem Cells Research (6 papers), Mesenchymal stem cell research (6 papers) and Hemoglobinopathies and Related Disorders (6 papers). The work is most often cited by research in Immunology (1.1k citations), Genetics (349 citations) and Immunology and Allergy (138 citations). Myriam Armant has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Marika Sarfati, Matthew J. Fenton, G Delespesse, Manuel Rubio, M Sarfati, Guy Delespesse, G Biron, Véronique Mateo, Laurence Lagneaux and G. Delespesse. Their work appears in journals such as Nature Medicine, Nature Communications and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.